357 related articles for article (PubMed ID: 25896401)
1. Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis.
Barczyk M; Schmidt M; Mattoli S
Stem Cell Rev Rep; 2015 Aug; 11(4):598-620. PubMed ID: 25896401
[TBL] [Abstract][Full Text] [Related]
2. Potential antitumor therapeutic strategies of human amniotic membrane and amniotic fluid-derived stem cells.
Kang NH; Hwang KA; Kim SU; Kim YB; Hyun SH; Jeung EB; Choi KC
Cancer Gene Ther; 2012 Aug; 19(8):517-22. PubMed ID: 22653384
[TBL] [Abstract][Full Text] [Related]
3. Amniotic membrane and amniotic cells: potential therapeutic tools to combat tissue inflammation and fibrosis?
Manuelpillai U; Moodley Y; Borlongan CV; Parolini O
Placenta; 2011 Oct; 32 Suppl 4():S320-5. PubMed ID: 21570115
[TBL] [Abstract][Full Text] [Related]
4. Cell-based therapies for the treatment of idiopathic pulmonary fibrosis (IPF) disease.
Ghadiri M; Young PM; Traini D
Expert Opin Biol Ther; 2016; 16(3):375-87. PubMed ID: 26593230
[TBL] [Abstract][Full Text] [Related]
5. Translating Basic Research into Safe and Effective Cell-based Treatments for Respiratory Diseases.
Ikonomou L; Wagner DE; Turner L; Weiss DJ
Ann Am Thorac Soc; 2019 Jun; 16(6):657-668. PubMed ID: 30917290
[TBL] [Abstract][Full Text] [Related]
6. Cell-Based Therapy for Fibrosing Interstitial Lung Diseases, Current Status, and Potential Applications of iPSC-Derived Cells.
Nakamura Y; Niho S; Shimizu Y
Cells; 2024 May; 13(11):. PubMed ID: 38891026
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial.
Glassberg MK; Minkiewicz J; Toonkel RL; Simonet ES; Rubio GA; DiFede D; Shafazand S; Khan A; Pujol MV; LaRussa VF; Lancaster LH; Rosen GD; Fishman J; Mageto YN; Mendizabal A; Hare JM
Chest; 2017 May; 151(5):971-981. PubMed ID: 27890713
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis.
Cargnoni A; Gibelli L; Tosini A; Signoroni PB; Nassuato C; Arienti D; Lombardi G; Albertini A; Wengler GS; Parolini O
Cell Transplant; 2009; 18(4):405-22. PubMed ID: 19622228
[TBL] [Abstract][Full Text] [Related]
9. Lung Regeneration: Endogenous and Exogenous Stem Cell Mediated Therapeutic Approaches.
Akram KM; Patel N; Spiteri MA; Forsyth NR
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26797607
[TBL] [Abstract][Full Text] [Related]
10. Stem Cell and Idiopathic Pulmonary Fibrosis: Mechanisms and Treatment.
Liu M; Ren D; Wu D; Zheng J; Tu W
Curr Stem Cell Res Ther; 2015; 10(6):466-76. PubMed ID: 25986617
[TBL] [Abstract][Full Text] [Related]
11. Multipotent Mesenchymal Stromal Cells for Pulmonary Fibrosis?
Purdon S; Patete CL; Glassberg MK
Am J Med Sci; 2019 May; 357(5):390-393. PubMed ID: 31010466
[TBL] [Abstract][Full Text] [Related]
12. ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective.
Pozzobon M; Ghionzoli M; De Coppi P
Pediatr Surg Int; 2010 Jan; 26(1):3-10. PubMed ID: 19727766
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of placenta-derived stem cells for liver diseases: current status and perspectives.
Miki T; Grubbs B
J Obstet Gynaecol Res; 2014 Feb; 40(2):360-8. PubMed ID: 24245961
[TBL] [Abstract][Full Text] [Related]
14. [Research and Application of Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis: A Review].
Feng XR; Yao J; Wu Y; Cheng X; Zou PJ; Wang H; Yang M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):373-379. PubMed ID: 34018353
[TBL] [Abstract][Full Text] [Related]
15. Stem Cell-Based Therapies for Liver Diseases: An Overview and Update.
Wang J; Sun M; Liu W; Li Y; Li M
Tissue Eng Regen Med; 2019 Apr; 16(2):107-118. PubMed ID: 30989038
[TBL] [Abstract][Full Text] [Related]
16. Pluripotent Stem Cells as a Robust Source of Mesenchymal Stem Cells.
Luzzani CD; Miriuka SG
Stem Cell Rev Rep; 2017 Feb; 13(1):68-78. PubMed ID: 27815690
[TBL] [Abstract][Full Text] [Related]
17. Amnion-derived cells as a reliable resource for next-generation regenerative medicine.
Umezawa A; Hasegawa A; Inoue M; Tanuma-Takahashi A; Kajiwara K; Makino H; Chikazawa E; Okamoto A
Placenta; 2019 Sep; 84():50-56. PubMed ID: 31272680
[TBL] [Abstract][Full Text] [Related]
18. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells.
Parolini O; Alviano F; Bagnara GP; Bilic G; Bühring HJ; Evangelista M; Hennerbichler S; Liu B; Magatti M; Mao N; Miki T; Marongiu F; Nakajima H; Nikaido T; Portmann-Lanz CB; Sankar V; Soncini M; Stadler G; Surbek D; Takahashi TA; Redl H; Sakuragawa N; Wolbank S; Zeisberger S; Zisch A; Strom SC
Stem Cells; 2008 Feb; 26(2):300-11. PubMed ID: 17975221
[TBL] [Abstract][Full Text] [Related]
19. The decision on the "optimal" human pluripotent stem cell.
Rosner M; Schipany K; Hengstschläger M
Stem Cells Transl Med; 2014 May; 3(5):553-9. PubMed ID: 24692589
[TBL] [Abstract][Full Text] [Related]
20. Stem cell characteristics and the therapeutic potential of amniotic epithelial cells.
Miki T
Am J Reprod Immunol; 2018 Oct; 80(4):e13003. PubMed ID: 29956869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
